Embera Neurotherapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.emberaneuro.com
Study of EMB-001 as a Potential Smoking Cessation Treatment
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT04933916
- Locations
- 🇺🇸
Embera Site, Miami Lakes, Florida, United States
🇺🇸Rose Research Center, Raleigh, North Carolina, United States
A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 82
- Registration Number
- NCT04501874
- Locations
- 🇺🇸
Pacific Treatment and Research Center, Department of Psychiatry, University of California, San Diego, School of Medicine, San Diego, California, United States
🇺🇸Segal Trials, Miami, Florida, United States
🇺🇸U PENN- Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations
- Conditions
- Interventions
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03404817
- Locations
- 🇺🇸
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
- Conditions
- Interventions
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02856854
- Locations
- 🇺🇸
Vince & Associates, Overland Park, Kansas, United States
Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)
- Conditions
- Interventions
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02406066
- Locations
- 🇺🇸
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
🇺🇸Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
- Conditions
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2008-12-31
- Lead Sponsor
- Embera NeuroTherapeutics, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00567814
- Locations
- 🇺🇸
Department of Psychiatry, Psychopharmacology Research Clinic, Shreveport, Louisiana, United States